It will be important to test whether re-expression of H2AX can restore GIST cell sensitivity to DNA damaging agents such as chemotherapeutic drugs or radiotherapy, which could be exploited for combination therapies. The gene discussed is H2AX; the disease is gastrointestinal stromal tumor.